Yukihiro Umeda

1.4k total citations
51 papers, 722 citations indexed

About

Yukihiro Umeda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Yukihiro Umeda has authored 51 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Yukihiro Umeda's work include Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Research Studies (12 papers). Yukihiro Umeda is often cited by papers focused on Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Research Studies (12 papers). Yukihiro Umeda collaborates with scholars based in Japan, United States and Germany. Yukihiro Umeda's co-authors include Yoshiki Demura, Shingo Ameshima, Takeshi Ishizaki, Hidehiko Okazawa, Miwa Morikawa, Yasuhisa Fujibayashi, Tatsuro Tsuchida, Maiko Kadowaki, Masaki Anzai and Tamotsu Ishizuka and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Annals of Oncology.

In The Last Decade

Yukihiro Umeda

47 papers receiving 709 citations

Peers

Countries citing papers authored by Yukihiro Umeda

Since Specialization

Citations

This map shows the geographic impact of Yukihiro Umeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukihiro Umeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukihiro Umeda more than expected).

Fields of papers citing papers by Yukihiro Umeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukihiro Umeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukihiro Umeda. The network helps show where Yukihiro Umeda may publish in the future.

Co-authorship network of co-authors of Yukihiro Umeda

This figure shows the co-authorship network connecting the top 25 collaborators of Yukihiro Umeda. A scholar is included among the top collaborators of Yukihiro Umeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukihiro Umeda. Yukihiro Umeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human T-cell Lymphotropic Virus Type-1-associated Bronchioloalveolar Disorder with Non-necrotizing Granulomas: A Case Report and Literature Review 2023 ·Internal Medicine ·(unknown), Yukihiro Umeda, Ryoko Egashira, Kazuhiro Tabata, (unknown), (unknown), Makiko Yamaguchi, Yuko Waseda, Yoshiaki Imamura, Takahiro Yamauchi, Tamotsu Ishizuka	0
2	Safety and utility of Endoscopic Ultrasound with Bronchoscope-guided Fine Needle Aspiration (EUS-B-FNA) in suspected lung cancer patients with poor respiratory or general conditions: a prospective three-center observational study 2023 ·BMC Pulmonary Medicine ·Koki Nakashima, Yukihiro Umeda, Yoshiki Demura, Toshihiro Takeda, (unknown), Masayuki Sato, (unknown), (unknown), (unknown), Makiko Yamaguchi, (unknown), (unknown), (unknown), Yuko Waseda, Masaki Anzai, (unknown), Tamotsu Ishizuka	8
3	Efficacy and safety of nanoparticle albumin‐bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non‐small cell lung cancer: A multicenter Phase 2 clinical trial 2023 ·Cancer Medicine ·(unknown), Yukihiro Umeda, Yoshiki Demura, (unknown), Koki Nakashima, Masaki Anzai, Makiko Yamaguchi, (unknown), (unknown), (unknown), Yuko Waseda, (unknown), Tamotsu Ishizuka	11
4	Sulfated Glycans Recognized by S1 Monoclonal Antibody can Serve as a Diagnostic Marker for Malignant Pleural Mesothelioma 2022 ·Lung ·Koki Nakashima, Yasuhiro Sakai, Hitomi Hoshino, Yukihiro Umeda, Hiroto Kawashima, Yoshitaka Sekido, Tamotsu Ishizuka, Motohiro Kobayashi	4
5	Surfactant protein D: a useful marker for differentiation of drug-induced pneumonia and bacterial pneumonia 2021 ·SHILAP Revista de lepidopterología ·Yuko Waseda, Masahide Yasui, (unknown), (unknown), Toshihiro Takeda, (unknown), (unknown), Makiko Yamaguchi, Satoshi Watanabe, Hazuki Takato, Yukari Ichikawa, Yukihiro Umeda, Masaki Anzai, Hiroshi Ueda, Kazuo Kasahara, Tamotsu Ishizuka	2
6	Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer 2020 ·Cancer Chemotherapy and Pharmacology ·Ou Yamaguchi, Hisao Imai, Hiroyuki Minemura, Kensuke Suzuki, (unknown), Yukihiro Umeda, Takashi Osaki, Norimitsu Kasahara, Junji Uchino, Tomohide Sugiyama, Shinichi Ishihara, Hisashi Ishii, Ichiro Naruse, Keita Mori, (unknown), Kenya Kanazawa, Koichi Minato, Hiroshi Kagamu, Kyoichi Kaira	39
7	P1.04-34 Efficacy and Safety of First-Line Pembrolizumab Monotherapy in Elderly Patients (Aged ≥ 75 years) with Non-Small Cell Lung Cancer 2019 ·Journal of Thoracic Oncology ·(unknown), Hisao Imai, (unknown), Ou Yamaguchi, Kensuke Suzuki, Junji Uchino, Hiroyuki Minemura, Takashi Osaki, Tatsuya Ishii, Yukihiro Umeda, Hirokazu Taniguchi, Takashi Kasai, Koichi Minato, Kyoichi Kaira	0
8	The vertebral 3′-deoxy-3′-18F-fluorothymidine uptake predicts the hematological toxicity after systemic chemotherapy in patients with lung cancer 2019 ·European Radiology ·Yukihiro Umeda, Tetsuya Tsujikawa, Masaki Anzai, Miwa Morikawa, Yuko Waseda, Maiko Kadowaki, Hiroko Shigemi, Shingo Ameshima, Tetsuya Mori, Yasushi Kiyono, Hidehiko Okazawa, Tamotsu Ishizuka	5
9	Extracellular acidification-induced CXCL8 production through a proton-sensing receptor OGR1 in human airway smooth muscle cells: a response inhibited by dexamethasone 2019 ·Journal of Inflammation ·Maiko Kadowaki, Hidenori Yamada, Kōichi Sato, Hiroko Shigemi, Yukihiro Umeda, Miwa Morikawa, Yuko Waseda, Masaki Anzai, Yosuke Kamide, Haruka Aoki‐Saito, Takeshi Hisada, Fumikazu Okajima, Tamotsu Ishizuka	15
10	Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer 2018 ·International Journal of Clinical Oncology ·(unknown), Ryoichi Yano, (unknown), (unknown), Shinji Yamashita, (unknown), Kyohei Watanabe, (unknown), Toshiaki Nakamura, Maiko Kadowaki, Miwa Morikawa, Yukihiro Umeda, Masaki Anzai, Tamotsu Ishizuka, Nobuyuki Goto	5
11	P2.02-024 Phase I and II Trial of Intrapleural Paclitaxel Injection for Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions 2017 ·Journal of Thoracic Oncology ·Masato Sasaki, (unknown), (unknown), Masaki Anzai, Miwa Morikawa, Yukihiro Umeda, Shingo Ameshima, Tamotsu Ishizuka, Takaaki Koshiji	1
12	Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer 2017 ·Medicine ·Masaki Anzai, Miwa Morikawa, (unknown), Yukihiro Umeda, Yoshiki Demura, (unknown), Makiko Yamaguchi, (unknown), (unknown), Shingo Ameshima, (unknown), Tamotsu Ishizuka	13
13	Blunted Activation of Rho-Kinase in Yak Pulmonary Circulation 2015 ·BioMed Research International ·Takeshi Ishizaki, Shiro Mizuno, Akio Sakai, Shigeru Matsukawa, Baktybek Kojonazarov, (unknown), Yukihiro Umeda, Miwa Morikawa, Masaki Anzai, Tamotsu Ishizuka, Almaz Aldashev	14
14	Prognostic Value of Dual-Time-Point ¹⁸F-FDG PET for Idiopathic Pulmonary Fibrosis 2015 ·Journal of Nuclear Medicine ·Yukihiro Umeda, Yoshiki Demura, Miwa Morikawa, Masaki Anzai, Maiko Kadowaki, Shingo Ameshima, Tatsuro Tsuchida, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Takeshi Ishizaki, Tamotsu Ishizuka	36
15	18F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancer 2014 ·Lung Cancer ·Yukihiro Umeda, Yoshiki Demura, Masaki Anzai, Hiroki Matsuoka, Tomoyuki Araya, Masaru Nishitsuji, Koichi Nishi, Tatsuro Tsuchida, (unknown), Miwa Morikawa, Shingo Ameshima, Takeshi Ishizaki, Kazuo Kasahara, Tamotsu Ishizuka	8
16	Prognostic value of dual‐time‐point ¹⁸F‐fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis 2011 ·Respirology ·Yukihiro Umeda, Yoshiki Demura, Miwa Morikawa, Shingo Ameshima, Tatsuro Tsuchida, Yasuhisa Fujibayashi, Hidehiko Okazawa, Takeshi Ishizaki	36
17	Small airway disease associated with Sjögren’s syndrome: Clinico-pathological correlations 2011 ·Respiratory Medicine ·Masanori Nakanishi, Junya Fukuoka, Tomonori Tanaka, Yoshiki Demura, Yukihiro Umeda, Shingo Ameshima, (unknown), Masanori Kitaichi, Harumi Itoh, Takeshi Ishizaki	20
18	Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathways 2009 ·Respiratory Research ·Shiro Mizuno, Harm Jan Bogaard, Norbert F. Voelkel, Yukihiro Umeda, Maiko Kadowaki, Shingo Ameshima, Isamu Miyamori, Takeshi Ishizaki	37
19	Multi-arterial infusion chemotherapy for non-small cell lung carcinoma—Significance of detecting feeding arteries and tumor staining 2008 ·Lung Cancer ·Masanori Nakanishi, Yoshiki Demura, Yukihiro Umeda, Shiro Mizuno, Shingo Ameshima, Yukio Chiba, Takeshi Ishizaki	37
20	Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: Four clinical specified cases 2006 ·Lung Cancer ·Masanori Nakanishi, Yukihiro Umeda, Yoshiki Demura, Shingo Ameshima, Yukio Chiba, Isamu Miyamori, Takeshi Ishizaki	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact